804 related articles for article (PubMed ID: 21223660)
1. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
[TBL] [Abstract][Full Text] [Related]
2. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
[No Abstract] [Full Text] [Related]
3. [Economic burden and related factors on inpatients with HBV-related diseases in Shandong province].
Lü JJ; Li RP; Xu AQ; Zhang L; Song LZ; Yan BY; Ji F; Liu JY; Fang XQ; Wang Z; Zhu DW; Zhang GJ; Feng Y; Xiao ZK; Wang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):267-72. PubMed ID: 23759235
[TBL] [Abstract][Full Text] [Related]
4. [Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases].
Ma QS; Zou YH; Zhang SX; Liang S; Xiao HW; Xie X; Mei SJ; Jia WD; Zhang YF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug; 32(8):764-7. PubMed ID: 22093463
[TBL] [Abstract][Full Text] [Related]
5. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
Hu M; Chen W
Value Health; 2009; 12 Suppl 3():S89-92. PubMed ID: 20586991
[TBL] [Abstract][Full Text] [Related]
6. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
[TBL] [Abstract][Full Text] [Related]
7. [Economic burden of hepatitis C patients and related influencing factors in Guangdong province].
Wu QM; Li Y; Fu XB; Yang F; Li J; Huang HZ; Yan J; Lin P
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul; 39(7):931-936. PubMed ID: 30060307
[No Abstract] [Full Text] [Related]
8. Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan province of China.
Che YH; Chongsuvivatwong V; Li L; Sriplung H; Wang YY; You J; Ma SJ; Yan Y; Zhang RY; Shen T; Chen HM; Rao SF; Zhang XL
Public Health; 2016 Jan; 130():13-20. PubMed ID: 25931438
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
10. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.
Ong SC; Lim SG; Li SC
J Viral Hepat; 2009 Jan; 16(1):53-63. PubMed ID: 19192158
[TBL] [Abstract][Full Text] [Related]
11. Annual economic burden of hepatitis B virus-related diseases among hospitalized patients in twelve cities in China.
Zhang S; Ma Q; Liang S; Xiao H; Zhuang G; Zou Y; Tan H; Liu J; Zhang Y; Zhang L; Feng X; Xue L; Hu D; Cui F; Liang X
J Viral Hepat; 2016 Mar; 23(3):202-10. PubMed ID: 26663525
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province].
Long Y; Lu J; Xu DZ; Hu JX; Jiang JH; Yan YP; Huang JY; Yang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):494-7. PubMed ID: 16334999
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
Zhang B; Zhang Y; Yang J; Liu X
Wei Sheng Yan Jiu; 2007 Nov; 36(6):706-10. PubMed ID: 18303632
[TBL] [Abstract][Full Text] [Related]
14. [The analysis of drug cost and direct medical expense in community health management of hypertensive patients].
Liang XH; Gu DF; Zhang H; Zhu K; Deng Y; Cao J; Zhou ZY; Wang Y; Wan GS; Zhao C; Mu QC; Lu FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):732-6. PubMed ID: 22169696
[TBL] [Abstract][Full Text] [Related]
15. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
[TBL] [Abstract][Full Text] [Related]
16. Resource use and cost of hepatitis C-related care.
Nevens F; Colle I; Michielsen P; Robaeys G; Moreno C; Caekelbergh K; Lamotte M; Wyffels V
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1191-8. PubMed ID: 22836284
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
18. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.
Chen X; Wang N; Chen Y; Xiao T; Fu C; Xu B
Int J Chron Obstruct Pulmon Dis; 2016; 11():2625-2632. PubMed ID: 27799761
[TBL] [Abstract][Full Text] [Related]
19. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China.
Xiao J; Lin H; Liu T; Zeng W; Li X; Shao X; Tan Q; Xu Y; Xu X; Zheng H; Ma W
Int J Environ Res Public Health; 2015 Nov; 12(11):14055-67. PubMed ID: 26540065
[TBL] [Abstract][Full Text] [Related]
20. Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.
Lee KK; Wu DB; Chow PY; Lee VW; Li H
J Gastroenterol Hepatol; 2012 Jul; 27(7):1167-74. PubMed ID: 22141402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
